500
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Reply to “mTOR inhibitor-related pulmonary toxicity; incidence even higher”

, &
Page 1235 | Received 04 Mar 2013, Accepted 08 Mar 2013, Published online: 25 Apr 2013

References

  • Willemsen AECAB, van Herpen CML. mTOR inhibitor related pulmonary toxicity; incidence even higher. Acta Oncol Epub 2013 Feb 14.
  • Iacovelli R, Palazzo A, Mezi S, Morano F, Naso G, Cortesi E. Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials. Acta Oncol 2012;51:873–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.